Diboronate-Modified Hyaluronic Acid for Glucose-Responsive Insulin Delivery
Biomacromolecules · 14.04.2025 · 26 (4) · 2700-2707
DOI: 10.1021/acs.biomac.5c00144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 27.03.2025. Verfasst von Sijie Xian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Indiana 46556, United States. Hauptthemen laut MEDLINE: Hyaluronic Acid, Insulin, Diabetes Mellitus, Experimental, Boronic Acids. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: American Diabetes Association, Leona M. and Harry B. Helmsley Charitable Trust, National Science Foundation.
Abstract (Originalsprache)
Diabetes requires precise insulin management to maintain glycemic control and prevent severe complications. Glucose-responsive delivery systems envision an autonomous approach to improve insulin therapy. Here, a glucose-sensitive insulin delivery system comprising hyaluronic acid conjugated with a diboronate glucose binder as a carrier for diol-modified insulin is shown. This approach seeks improved precision in insulin delivery, leveraging bidentate glucose binding to achieve enhanced glucose affinity and specificity. Modification of insulin with a diol motif preserves its native conformation and function. These insulin formulations correct blood glucose in diabetic mice, including glucose-responsive function when subjected to a glucose challenge. However, the absence of secondary interactions, such as electrostatic complexation, ultimately limits the duration of function relative to that of previous platforms. Integrating complementary interactions alongside dynamic-covalent glucose binders therefore enhances the functional duration and therapeutic efficacy in the design of glucose-responsive polymeric carriers, offering design insights into the development of new carriers for glucose-responsive insulin delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Indiana 46556, United States.
- Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Prague 16610, Czech Republic.
ORCID-Profile: Yuanhui Xiang, Matthew J Webber
Förderung
- American Diabetes Association
- Leona M. and Harry B. Helmsley Charitable Trust
- National Science Foundation
- Breakthrough T1D
Zitieren
APA
Xian, S., Xiang, Y., Mitrová, K., Jiráček, J., & Webber, M. J. (2025). Diboronate-Modified Hyaluronic Acid for Glucose-Responsive Insulin Delivery. Biomacromolecules, 26(4), 2700-2707. https://doi.org/10.1021/acs.biomac.5c00144
Vancouver
Xian S, Xiang Y, Mitrová K, Jiráček J, Webber MJ. Diboronate-Modified Hyaluronic Acid for Glucose-Responsive Insulin Delivery. Biomacromolecules. 2025;26(4):2700-2707. doi:10.1021/acs.biomac.5c00144
BibTeX
@article{Xian2025,
author = {Xian, Sijie and Xiang, Yuanhui and Mitrová, Katarína and Jiráček, Jiří and Webber, Matthew J},
title = {Diboronate-Modified Hyaluronic Acid for Glucose-Responsive Insulin Delivery},
journal = {Biomacromolecules},
year = {2025},
volume = {26},
number = {4},
pages = {2700--2707},
doi = {10.1021/acs.biomac.5c00144}
}
EUVIMED